About
Bio
Provides new and interesting insights into epigenetic inheritance and chromatin-based interactions. Topics include gene silencing and imprinting, cellular reprogramming, nucleosome modification assembly and remodeling, DNA methylation, chromatin structure and dynamics, chromosomal maintenance elements, dosage compensation, interchromosomal interactions and prion inheritance.
The outlet offers RSS (Really Simple Syndication).
Email
email@cision.one
Website
site@cision.one
Social media
Location
United Kingdom
Frequency
upgrade
Circulation
upgrade
Sectors
Genetics
Bio
Provides new and interesting insights into epigenetic inheritance and chromatin-based interactions. Topics include gene silencing and imprinting, cellular reprogramming, nucleosome modification assembly and remodeling, DNA methylation, chromatin structure and dynamics, chromosomal maintenance elements, dosage compensation, interchromosomal interactions and prion inheritance. The outlet offers RSS (Really Simple Syndication).
Website
Social media
Location
Frequency
Circulation
Sectors
Genetics
Most recent articles by Epigenetics & Chromatin
Lorem ipsum dolor sit amet, consectetur adipiscing elit
Article description
Lorem ipsum dolor sit amet, consectetur adipiscing elit
Article description
Lorem ipsum dolor sit amet, consectetur adipiscing elit
Article description
Explore outlets similar to Epigenetics & Chromatin
-
GenomeWeb
This is the online home for all GenomeWeb LLC outlets. It provides links to newsletter sections. It covers news and trends in the world of genomics which focuses on biotech, science, healthcare and medicine. It includes information on enterprise bioinformatics, high-performance computing, genomic data and database integration, DNA amplification and sequencing, genome assembly and gene prediction. The outlet offers RSS (Really Simple Syndication).
ViewGenetic Engineering & Biotechnology NewsEstablished in 1981 and written for biotech and biopharma professionals involved in research, technical and commercial management. Provides coverage of biotechnology news and developments, scale-up and bioprocess technologies, regulatory and legal issues, new products and R&D and novel drug discovery techniques. Also includes financial news (public offerings, mergers and venture capital investments), funding and government news, corporate profiles, university news, meeting reports, international round-ups and literature information and articles relating to research projects and the production of biotechnology products.Regular topics in the publication include drug discovery technologies and R&D, trends in instrumentation, genomics and downstream omics, gene therapy, industrial biotechnology, enzymes, bioprocessing strategies, contract manufacture, monoclonal antibodies, bioinformatics, cell culture, LIMS, business issues and regulatory issues.Features the channels: Biobusiness which covers financial, business or patent related; Drug Discovery handles technical issues related to early stages of research and finding new pharmaceuticals; Omics spotlights genomics, proteomics and technologies such as metabolomics and Translational Medicine focuses on clinical and scientific efforts that concerns research and clinical settings. Other sections: Podcasts; Blogs; New Products; Best of the Web; GEN Updates RNAi; Oligonucleotides; Next-Generation Sequencing; Jobs; Classified Mart Marketplace; Real Estate; Conferences/Meetings; and Biotech Companies.The site offers RSS (Really Simple Syndication) and a digital Podcast.The publication DOES accept article submissions. Articles should be submitted to Managing Editor. Articles can be submitted either as POV articles, tutorials, overviews for the Transitional Medicine section, or online. For POV articles, they should be submitted one to two months in advance and should be about 1000 words. For tutorials, the articles should be submitted 4-6 months in advance and should be 1000-12000 words. For the Transitional Medicine section, these articles should be overviews, as opposed to specific points of view. They should also be 1000 words. For the online perspectives, they should be submitted a week before.
ViewMicrobiology and Molecular Biology ReviewsWritten for members of the American Society for Microbiology. Serves as the definitive, broad-based review journal in the disciplines of microbiology, immunology, and molecular ad cellular biology, keeping readers abreast of the latest findings about bacteria, viruses, parasites, fungi and other higher eukaryotes. Covers Physiology and enzymology, Molecular biology, Chemistry; biosynthesis, Genetics, Ecology, Host-parasite relationships leading to disease, Cellular biology and Virology. Media Kit: http://journals.asm.org/site/misc/ASM_Media_Kit2016.pdf
ViewJournal of VirologyPublishes broad-based, high-quality and original research on viruses and provides information from cross-studies on biochemistry, biophysics, cell biology, genetics, immunology, molecular biology, morphology, physiology, and pathogenesis and immunity. Covers Structure and Assembly, Genome Replication and Regulation of Viral Gene Expression, Genetic Diversity and Evolution, Virus-Cell Interactions Cellular Response to Infection, Transformation and Oncogenesis, Gene Delivery Vaccines and Antiviral Agents, Pathogenesis and ImmunityBiology.
ViewGGenetic Testing and Molecular BiomarkersFormerly called Genetic Testing and written for medical researchers specializing in genetics testing. Covers all aspects of genetic testing including prenatal diagnosis, risk assessment, clinical consequences of molecular genetics, results of population screens and targeted testing, methodologies, strategies and ethical and legal issues
ViewUse CisionOne to find more relevant outletsContact Epigenetics & Chromatin and get access to over 850K accurate, up-to-date media profiles.
Discover the stories that impact your brand. In realtime.
CisionOne delivers relevant news, trends and conversations that matter to your brand with the world’s most comprehensive media monitoring service across Print, Online, TV, Radio, Social, Magazines, Podcasts and more.